Neurotensin-loaded collagen dressings reduce inflammation and improve wound healing in diabetic mice
- PMID: 24161538
- DOI: 10.1016/j.bbadis.2013.10.009
Neurotensin-loaded collagen dressings reduce inflammation and improve wound healing in diabetic mice
Abstract
Impaired wound healing is an important clinical problem in diabetes mellitus and results in failure to completely heal diabetic foot ulcers (DFUs), which may lead to lower extremity amputations. In the present study, collagen based dressings were prepared to be applied as support for the delivery of neurotensin (NT), a neuropeptide that acts as an inflammatory modulator in wound healing. The performance of NT alone and NT-loaded collagen matrices to treat wounds in streptozotocin (STZ) diabetic induced mice was evaluated. Results showed that the prepared dressings were not-cytotoxic up to 72h after contact with macrophages (Raw 264.7) and human keratinocyte (HaCaT) cell lines. Moreover, those cells were shown to adhere to the collagen matrices without noticeable change in their morphology. NT-loaded collagen dressings induced faster healing (17% wound area reduction) in the early phases of wound healing in diabetic wounded mice. In addition, they also significantly reduced inflammatory cytokine expression namely, TNF-α (p<0.01) and IL-1β (p<0.01) and decreased the inflammatory infiltrate at day 3 post-wounding (inflammatory phase). After complete healing, metalloproteinase 9 (MMP-9) is reduced in diabetic skin (p<0.05) which significantly increased fibroblast migration and collagen (collagen type I, alpha 2 (COL1A2) and collagen type III, alpha 1 (COL3A1)) expression and deposition. These results suggest that collagen-based dressings can be an effective support for NT release into diabetic wound enhancing the healing process. Nevertheless, a more prominent scar is observed in diabetic wounds treated with collagen when compared to the treatment with NT alone.
Keywords: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; AUC; COL1A1; COL1A2; COL3A1; Collagen; DFU; Diabetic foot ulcer; ECM; EGF; FBS; IL-1β; IL-6; KC; MMP-9; MTT; NO; NT; Neurotensin; PBS; PDGF; PMN; SEM; STZ; TGF β1; TGF β3; TNF-α; VEGF; Wound dressing; Wound healing; area under the curve; collagen type I, alpha 1; collagen type I, alpha 2; collagen type III, alpha 1; diabetic foot ulcer; endothelial growth factor; extracellular matrix; fetal bovine serum; interleukin-1β; interleukin-6; interleukin-8; metalloproteinase 9; neurotensin; nitric oxide; phosphate buffer solution; platelet-derived growth factor; polymorphonuclear leukocytes; scanning electron microscopy; streptozotocin; transforming growth factor β1; transforming growth factor β3; tumor necrosis factor-α; vascular endothelial growth factor.
© 2013.
Similar articles
-
Chitosan-based dressings loaded with neurotensin--an efficient strategy to improve early diabetic wound healing.Acta Biomater. 2014 Feb;10(2):843-57. doi: 10.1016/j.actbio.2013.09.040. Epub 2013 Oct 10. Acta Biomater. 2014. PMID: 24121197
-
[Effect of hydrocinnamoyl-L-valyl pyrrolidine on healing quality of deep partial-thickness scald wound in mice].Zhonghua Shao Shang Za Zhi. 2016 Nov 20;32(11):658-666. doi: 10.3760/cma.j.issn.1009-2587.2016.11.005. Zhonghua Shao Shang Za Zhi. 2016. PMID: 27894387 Chinese.
-
Improvement of skin wound healing in diabetic mice by kinin B2 receptor blockade.Clin Sci (Lond). 2016 Jan;130(1):45-56. doi: 10.1042/CS20150295. Epub 2015 Oct 6. Clin Sci (Lond). 2016. PMID: 26443866
-
Strategy for Treatment of Infected Diabetic Foot Ulcers.Acc Chem Res. 2021 Mar 2;54(5):1080-1093. doi: 10.1021/acs.accounts.0c00864. Epub 2021 Feb 17. Acc Chem Res. 2021. PMID: 33596041 Review.
-
[The modern approach to wound treatment].Med Pregl. 2000 Jul-Aug;53(7-8):363-8. Med Pregl. 2000. PMID: 11214479 Review. Croatian.
Cited by
-
Beneficial Effects of Neurotensin in Murine Model of Hapten-Induced Asthma.Int J Mol Sci. 2019 Oct 11;20(20):5025. doi: 10.3390/ijms20205025. Int J Mol Sci. 2019. PMID: 31614422 Free PMC article.
-
microRNA-155 inhibition restores Fibroblast Growth Factor 7 expression in diabetic skin and decreases wound inflammation.Sci Rep. 2019 Apr 9;9(1):5836. doi: 10.1038/s41598-019-42309-4. Sci Rep. 2019. PMID: 30967591 Free PMC article.
-
Innovations in gene and growth factor delivery systems for diabetic wound healing.J Tissue Eng Regen Med. 2018 Jan;12(1):e296-e312. doi: 10.1002/term.2443. Epub 2017 Sep 21. J Tissue Eng Regen Med. 2018. PMID: 28482114 Free PMC article. Review.
-
A Concise Review on Tissue Engineered Artificial Skin Grafts for Chronic Wound Treatment: Can We Reconstruct Functional Skin Tissue In Vitro?Cells. 2020 Jul 6;9(7):1622. doi: 10.3390/cells9071622. Cells. 2020. PMID: 32640572 Free PMC article. Review.
-
Diabetic Foot Ulcers: Current Advances in Antimicrobial Therapies and Emerging Treatments.Antibiotics (Basel). 2019 Oct 24;8(4):193. doi: 10.3390/antibiotics8040193. Antibiotics (Basel). 2019. PMID: 31652990 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous